|
Outcome
|
Number of event (%)
|
Statin vs. non-statin
|
|---|
|
Statin (n = 441)
|
Non-statin (n = 441)
|
HR (95% CI)
|
P value
|
|---|
|
All-cause mortality
|
250 (56.7)
|
271 (61.5)
|
.70 (.59, .84)
|
<.001
|
|
Hemorrhage stroke
|
4 (.9)
|
2 (.5)
|
1.23 (.22, 6.84)
|
.810
|
|
Heart failure
|
59 (13.4)
|
44 (10.0)
|
1.08 (.73, 1.60)
|
.714
|
|
Acute hepatitis
|
1 (.2)
|
3 (.7)
|
.22 (.02, 2.16)
|
.194
|
|
Rhabdomyolysis
|
4 (.9)
|
1 (.2)
|
3.36 (.38, 30.06)
|
.279
|
|
Newly diagnosed dementia
|
0 (.0)
|
1 (.2)
|
NA
|
NA
|
|
Newly diagnosed malignancy
|
14 (3.2)
|
9 (2.0)
|
1.09 (.46, 2.56)
|
.844
|
-
CI confidence interval, HR hazard ratio, NA not applicable
